Dr. Avi Molcho is a venture partner at Forbion Capital Partners, a Dutch life science venture capital firm.
After graduating from the Tel Aviv University Medical School, Dr. Molcho served as the Chief Medical Officer of the Naval Commando (Navy Seals) of the Israeli Defense Forces (IDF).

Dr. Molcho had his residency in psychiatry and postdoctoral fellowship in psychopharmacology at Columbia University, Presbyterian Medical Center in New York, where he also served as a unit chief. In Israel, Dr. Molcho was Deputy Director General of The Abarbanel Mental Health Center, Tel Aviv University Medical School, the head of the residency program and the chief editor of the Israel National Boards of Psychiatry.

After completing an MBA program at the Tel Aviv University, Dr. Molcho joined Giza Venture Capital, an Israeli venture capital firm, as a managing Director, to head the firm’s life science practice.  Dr. Molcho was CEO of Neovasc, an Israeli medical device company, and led it through a turn around to acquisition. DR. Molcho is a cofounder of BiolineRX and a founder of Biologic Design, two Israeli drug development companies. Dr. Molcho serves on the Boards of Pathway medical Inc. and Circulite Inc.